Specific properties of probiotic strains: relevance and benefits for the host
Probiotics have tremendous potential to develop healthy diets, treatment, and prevention. Investigation of in vitro cultural properties of health-promoting microorganisms like lactic acid bacteria (LAB) and bifidobacteria is crucial to select probiotic strains for treatments based on gut microbiota modulation to justify individualized and personalized approach for nutrition and prevention of variety of diseases. The aim was to study the biological properties of LAB and bifidobacteria probiotic strains, namely adhesive properties; resistance to antibiotics; and biological fluids (gastric juice, bile, pancreatic enzymes), and to overview the literature in the field.
Materials and methods
We studied six LAB strains (Lactobacillus acidophilus ІМV В-7279, L. casei ІМV В-7280, L. delbrueckii subsp. bulgaricus ІМV В-7281, L. rhamnosus LB-3 VK6, L. delbrueckii LE VK8, L. plantarum LM VK7), and two bifidobacteria strains (Bifidobacterium animalis VKL, B. animalis VKB). We characterized tinctorial, culturally morphological, physiological, and biochemical properties of probiotic strains of LAB and bifidobacteria by commonly used research methods. Determination of the resistance to antibiotics was carried out using disc-diffusion method. The effects of gastric juice, bile, and pancreatin on the viability of LAB and bifidobacteria were evaluated. Adhesive properties of LAB and bifidobacteria to epithelial cells were assessed calculating three indicators: average adhesion rate (AAR), participation rate of epithelial cells (PRE), and adhesiveness index of microorganisms (AIM). Electron microscopy of LAB and bifidobacteria cells was conducted.
The studied strains of LAB and bifidobacteria did not form spores, were positively stained by Gram, grow on medium in a wide range of pH (1.0–9.0, optimum pH 5.5–6.5), were sensitive to a wide range of antibiotics; and showed different resistance to gastric juice, bile, and pancreatic enzymes. The most resistant to antibiotics were L. rhamnosus LB-3 VK6 and L. delbrueckii LE VK8 strains. The most susceptible to gastric juice was L. plantarum LM VK7, which stopped its growth at 8% of gastric juice; L. acidophilus IMV B-7279, B. animalis VKL, and B. animalis VKB strains were resistant even in the 100% concentration. Strains L. acidophilus IMV В-7279, L. casei IMV В-7280, B. animalis VKL, B. animalis VKB, L. rhamnosus LB-3 VK6, L. delbrueckii LE VK8, and L. delbrueckii subsp. bulgaricus IMV В-7281 were resistant to pancreatic enzymes. Adhesive properties of the strains according to AIM index were high in L. casei IMV В-7280, B. animalis VKL, and B. animalis VKB; were moderate in L. delbrueckii subsp. bulgaricus IMV В-7281; and were low in L. acidophilus IMV В-7279, L. rhamnosus LB-3 VK6, L. delbrueckii LE VK8, and L. plantarum LM VK7.
We recognized strain-dependent properties of studied LAB and bifidobacteria probiotic strains (adhesive ability, resistance to antibiotics, and gut biological fluids) and discussed potential for most effective individualized treatment for gut and distant sites microbiome modulation.
KeywordsPredictive preventive personalized medicine Lactobacillus Bifidobacterium Probiotics Gut microbiota Antibiotics Gastric juice Bile Pancreatic enzymes Adhesive properties Pili Patient phenotype Individualized medicine
The study was conducted with the support of the State Agency on Science, Innovations, and Informatization of Ukraine.
RVB suggested the idea and design of the study, participated in experiments, did the study analysis, prepared discussion, formulated future outlooks, and performed article drafting. LML and LPB prepared the first draft of manuscript, did the literature analysis, interpreted the results, and performed the statistical analysis. LPB and LML, performed the experiments on animals and participated analysis of the study. VVM performed the experiments. MYS did the organization, revision manuscript, and data interpretation, and contributed to the overall development of the studied topic. All authors read and approved the final manuscript.
Compliance with ethical standards
Ethics approval and consent to participate
Consent for publication
Availability of data and material
The authors declare that they have no competing interests.
- 2.WHO/FAO scientific document. http://who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf. Accessed 11 Feb 2018.
- 3.Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;8:506–14. https://doi.org/10.1038/nrgastro.2014.66.CrossRefGoogle Scholar
- 4.Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491–502. https://doi.org/10.1038/nrgastro.2017.75. PubMedCrossRefGoogle Scholar
- 6.Aron-Wisnewsky J, Clément K. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat Rev Nephrol. 2016 Mar;12(3):169-81. doi: 10.1038/nrneph.2015.191.Google Scholar
- 8.Bubnov RV, Babenko LP, Lazarenko LM, Mokrozub VV, Demchenko OA, Nechypurenko OV, et al. Comparative study of probiotic effects of lactobacillus and bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice. EPMA J. 2017;8(4):357–76. https://doi.org/10.1007/s13167-017-0117-3.CrossRefPubMedGoogle Scholar
- 10.Lebeer S, Bron PA, Marco ML, VanPijkeren JP, O'Connell Motherway M, Hill C, et al. Identification of probiotic effector molecules: present state and future perspectives. Curr Opin Biotechnol. 2017;49:217–23. https://doi.org/10.1016/j.copbio.2017.10.007.
- 14.Shapiro H, Suez J, Elinav E. Personalized microbiome-based approaches to metabolic syndrome management and prevention. J Diabetes. 2017;9(3):226–36. https://doi.org/10.1111/1753-0407.12501. Review.
- 15.Dao MC, Clément K. Gut microbiota and obesity: Concepts relevant to clinical care. Eur J Intern Med. 2018;48:18-24. https://doi.org/10.1016/j.ejim.2017.10.005.
- 25.D'Aimmo MR, Mattarelli P, Biavati B, Carlsson NG, Andlid T. The potential of bifidobacteria as a source of natural folate. J Appl Microbiol. 2012;112(5):975–84. https://doi.org/10.1111/j.1365-2672.2012.05261.x.
- 27.Gao C, Ganesh BP, Shi Z, Shah RR, Fultz R, Major A, et al. Gut microbe-mediated suppression of inflammation-associated colon carcinogenesis by luminal histamine production. Am J Pathol. 2017 Oct;187(10):2323–36. https://doi.org/10.1016/j.ajpath.2017.06.011.
- 28.Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab. 2012;61(2):160–74. https://doi.org/10.1159/000342079.
- 29.Rodrigues RR, Greer RL, Dong X, DSouza KN, Gurung M, Wu JY, et al. Antibiotic-induced alterations in gut microbiota are associated with changes in glucose metabolism in healthy mice. Front Microbiol. 2017;8:2306. https://doi.org/10.3389/fmicb.2017.02306.
- 32.Avdeeva LV, Osadchaia AI, Kharkhota MA. Influence of lactitol and lactulose on adhesion properties of Bacillus subtilis probiotic strains. Mikrobiol Z. 2012;74(5):22–5.Google Scholar
- 33.Lagier JC, Armougom F, Million M, Hugon P, Pagnier I, Robert C, et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect. 2012;18:1185–93.Google Scholar
- 35.Lagier JC, Khelaifia S, Alou MT, Ndongo S, Dione N, Hugon P, Caputo A, Cadoret F, Traore SI, Seck EH et al.: Culture of previously uncultured members of the human gut microbiota by culturomics. 2016;1:16203. doi: https://doi.org/10.1038/nmicrobiol.2016.203.
- 36.Browne HP, Forster SC, Anonye BO, Kumar N, Neville BA, Stares MD, et al. Culturing of “unculturable” human microbiota reveals novel taxa and extensive sporulation. Nature. 2016 May 26;533(7604):543–6. https://doi.org/10.1038/nature17645.
- 38.Kobayashi H, Kanmani P, Ishizuka T, Miyazaki A, Soma J, Albarracin L, et al. Development of an in vitro immunobiotic evaluation system against rotavirus infection in bovine intestinal epitheliocytes. Benef Microbes. 2017;8:309–21. https://doi.org/10.3920/BM2016.0155.
- 41.Hidalgo-Cantabrana C, Sánchez B, Álvarez-Martín P, López P, Martínez-Álvarez N, Delley M, et al. A single mutation in the gene responsible for the mucoid phenotype of Bifidobacterium animalis subsp. lactis confers surface and functional characteristics. ApplEnvironMicrobiol. 2015;81(23):7960–8. https://doi.org/10.1128/AEM.02095-15.
- 42.Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol. 2000;78(1):80–8.Google Scholar
- 52.Tannock GW, Luchansky JB, Miller L, Connell H, Thode-Andersen S, Mercer AA, et al. Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63. Plasmid. 1994;31(1):60–71.Google Scholar
- 59.Nie YF, Hu J, Yan XH. Cross-talk between bile acids and intestinal microbiota in host metabolism and health. J Zhejiang Univ Sci B. 2015 Jun; 16(6):436-46. doi: 10.1631/jzus.B1400327Google Scholar
- 61.Gu Y, Wang X, Li J, Zhang Y, Zhong H, Liu R, et al. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment. Nat Commun. 2017;8(1):1785. https://doi.org/10.1038/s41467-017-01682-2.
- 63.Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6:320–9.Google Scholar
- 64.Del Piano M, Strozzi P, Barba M, Allesina S, Deidda F, Lorenzini P, et al. In vitro sensitivity of probiotics to human pancreatic juice. J Clin Gastroenterol. 2008;42(Suppl 3 Pt 2):S170–3. https://doi.org/10.1097/MCG.0b013e3181815976.
- 66.Lebeer S, Vanderleyden J, De Keersmaecker SC. Genes and molecules of lactobacilli supporting probiotic action. Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Microbiol Mol Biol Rev. 2008;72(4):728–64.CrossRefPubMedPubMedCentralGoogle Scholar
- 67.Lebeer S, Claes I, Tytgat HL, Verhoeven TL, Marien E, von Ossowski I, et al. Functional analysis of lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol. 2012;78(1):185–93. https://doi.org/10.1128/AEM.06192-11.
- 68.von Ossowski I, Reunanen J, Satokari R, Vesterlund S, Kankainen M, Huhtinen H, et al. Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Appl Environ Microbiol. 2010;76(7):2049–57. https://doi.org/10.1128/AEM.01958-09.
- 69.Tytgat HL, van Teijlingen NH, Sullan RM, Douillard FP, Rasinkangas P, Messing M, et al. Probiotic gut microbiota isolate interacts with dendritic cells via glycosylated heterotrimeric pili. PLoS One. 2016;11(3):e0151824. https://doi.org/10.1371/journal.pone.0151824. eCollection 2016.
- 70.Burgain J, Scher J, Lebeer S, Vanderleyden J, Corgneau M, Guerin J, et al. Impacts of pH-mediated EPS structure on probiotic bacterial pili-whey proteins interactions. Colloids Surf B Biointerfaces. 2015;134:332–8. https://doi.org/10.1016/j.colsurfb.2015.06.068. Epub 2015 Jul 15
- 71.Burgain J, Gaiani C, Francius G, Revol-Junelles AM, Cailliez-Grimal C, Lebeer S, et al. In vitro interactions between probiotic bacteria and milk proteins probed by atomic force microscopy. Colloids Surf B Biointerfaces. 2013;104:153–62. https://doi.org/10.1016/j.colsurfb.2012.11.032.
- 72.Tytgat HL, Schoofs G, Vanderleyden J, Van Damme EJ, Wattiez R, Lebeer S, et al. Systematic exploration of the glycoproteome of the beneficial gut isolate Lactobacillus rhamnosus GG. J Mol Microbiol Biotechnol. 2016;26(5):345–58. https://doi.org/10.1159/000447091.
- 73.Guerin J, Burgain J, Borges F, Bhandari B, Desobry S, Scher J, et al. Use of imaging techniques to identify efficient controlled release systems of lactobacillus rhamnosus GG during in vitro digestion. Food Funct. 2017;8(4):1587–98. https://doi.org/10.1039/c6fo01737a.
- 74.Tripathi P, Beaussart A, Alsteens D, Dupres V, Claes I, von Ossowski I, et al. Adhesion and nanomechanics of pili from the probiotic Lactobacillus rhamnosus GG. ACS Nano. 2013;7(4):3685–97. https://doi.org/10.1021/nn400705u.
- 75.Garcia SL, Buck M, McMahon KD, Grossart HP, Eiler A, Auxotrophy WF. Intrapopulation complementary in the ‘interactome’ of a cultivated freshwater model community. Mol Ecol. 2015;24(17):4449–59. https://doi.org/10.1111/mec.13319.
- 76.Garcia SL, Stevens SLR, Crary B, Martinez-Garcia M, Stepanauskas R, Woyke T, et al. Contrasting patterns of genome-level diversity across distinct co-occurring bacterial populations. ISME J. 2018;12(3):745-55. doi: https://doi.org/10.1038/s41396-017-0001-0
- 77.Salas-Jara MJ, Ilabaca A, Vega M, García A. Biofilm forming Lactobacillus: new challenges for the development of probiotics. Microorganisms. 2016;4(3). https://doi.org/10.3390/microorganisms4030035.
- 78.O'Connell Motherway M, Zomer A, Leahy SC, Reunanen J, Bottacini F, Claesson MJ, et al. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11217–22. https://doi.org/10.1073/pnas.1105380108.
- 79.Shokryazdan P, Sieo CC, Kalavathy R, Liang JB, Alitheen NB, Faseleh Jahromi M, et al. Probiotic potential of lactobacillus strains with antimicrobial activity against some human pathogenic strains. Biomed Res Int. 2014;2014:927268. https://doi.org/10.1155/2014/927268.
- 80.He S, Ran C, Qin C, Li S, Zhang H, de Vos WM, et al. Anti-infective effect of adhesive probiotic lactobacillus in fish is correlated with their spatial distribution in the intestinal tissue. Sci Rep. 2017;7:13195. https://doi.org/10.1038/s41598-017-13466-1.
- 83.Jiang TT, Shao TY, Ang WXG, Kinder JM, Turner LH, Pham G, et al. Commensal Fungi recapitulate the protective benefits of intestinal bacteria. Cell Host Microbe. 2017;22(6):809–816.e4. https://doi.org/10.1016/j.chom.2017.10.013.
- 84.Ilavenil S, Park HS, Vijayakumar M, Arasu MV, Kim DH, Ravikumar S, et al. Probiotic potential of lactobacillus strains with antifungal activity isolated from animal manure. ScientificWorldJournal. 2015;2015:802570. https://doi.org/10.1155/2015/802570.
- 85.Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486:222–7. https://doi.org/10.1038/nature11053
- 86.De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691–6. https://doi.org/10.1073/pnas.1005963107.CrossRefPubMedPubMedCentralGoogle Scholar
- 87.Kong LC, Holmes BA, Cotillard A, Habi-Rachedi F, Brazeilles R, Gougis S, et al. Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS One. 2014;9:e109434. https://doi.org/10.1371/journal.pone.0109434.
- 89.Beaumont M, Goodrich JK, Jackson MA, Yet I, Davenport ER, Vieira-Silva S, et al. Heritable components of the human fecal microbiome are associated with visceral fat. Genome Biol. 2016;17:189. https://doi.org/10.1186/s13059-016-1052-7.
- 90.Org E, Blum Y, Kasela S, Mehrabian M, Kuusisto J, Kangas AJ, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol. 2017;18:70. https://doi.org/10.1186/s13059-017-1194-2.
- 91.Liu J, Chen FH, Qiu SQ, Yang LT, Zhang HP, Liu JQ, et al. Probiotics enhance the effect of allergy immunotherapy on regulating antigen specific B cell activity in asthma patients. Am J Transl Res. 2016 Dec 15;8(12):5256–70.Google Scholar
- 93.Konopelniuk VV, Goloborodko II, Ishchuk TV, Synelnyk TB, Ostapchenko LI, Spivak MY, et al. Efficacy of fenugreek-based bionanocomposite on renal dysfunction and endogenous intoxication in high-calorie diet-induced obesity rat model-comparative study. EPMA J. 2017;8(4):377–90. https://doi.org/10.1007/s13167-017-0098-2.
- 96.Dillon SM, Frank DN, Wilson CC. The gut microbiome and HIV-1 pathogenesis: a two-way street. AIDS. 2016;30(18):2737–51.Google Scholar
- 100.Wang Y, Kirpich I, Liu Y, Ma Z, Barve S, McClain CJ, et al. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol. 2011;179(6):2866–75. https://doi.org/10.1016/j.ajpath.2011.08.039.
- 101.Bubnov R, Jr PJ, Zubor P, Koniczka K, Golubnitschaja O. Pre-metastatic niches in breast cancer: are they created by or prior to the tumour onset? “Flammer syndrome” relevance to address the question. EPMA J. 2017;8:141–57. https://doi.org/10.1007/s13167-017-0092-8.CrossRefPubMedPubMedCentralGoogle Scholar
- 102.Bubnov RV. Ultrasonography diagnostic capability for mesenteric vascular disorders. Gut. 2011;60(Suppl 3):A104.Google Scholar
- 103.Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124(7):1174–82.Google Scholar
- 104.Grech G, Zhan X, Yoo BC, Bubnov R, Hagan S, Danesi R, et al. Position paper in cancer: current overview and future perspectives. EPMA J. 2015;6(1):9. https://doi.org/10.1186/s13167-015-0030-6.
- 106.Kobyliak NM, Falalyeyeva TM, Kuryk OG, Beregova TV, Bodnar PM, Zholobak NM, et al. Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative concept of men health and fertility. EPMA J. 2015 Jun 10;6(1):12. https://doi.org/10.1186/s13167-015-0034-2.
- 107.Babenko L, Bubnov R, Lazarenko L, Mokrozub V, Ganova L Kiseleva E, Shevchuk V, Spivak M. Use of probiotic bacteria increase effectiveness of vactination against hepatitis B in experimental studies Reviews in antiviral therapy infectious diseases (abstract book of the 3rd CEE meeting on viral hepatitis and co-infection with HIV, 27-28 September 2017, Ljubliana, Slovenia) 2017, 9:35.Google Scholar
- 108.Vitetta L, Saltzman ET, Thomsen M, Nikov T, Hall S. Adjuvant probiotics and the intestinal microbiome: enhancing vaccines and immunotherapy outcomes. Vaccines (Basel). 2017;5 (4). doi: https://doi.org/10.3390/vaccines5040050.
- 109.Kassaian N, Aminorroaya A, Feizi A, Jafari P, Amini M. The effects of probiotic and synbiotic supplementation on metabolic syndrome indices in adults at risk of type 2 diabetes: study protocol for a randomized controlled trial. Trials. 2017;18(1):148. https://doi.org/10.1186/s13063-017-1885-8.